157 related articles for article (PubMed ID: 23042022)
21. Sirolimus improves pain in NF1 patients with severe plexiform neurofibromas.
Hua C; Zehou O; Ducassou S; Minard-Colin V; Hamel-Teillac D; Wolkenstein P; Valeyrie-Allanore L
Pediatrics; 2014 Jun; 133(6):e1792-7. PubMed ID: 24864177
[TBL] [Abstract][Full Text] [Related]
22. Plexiform neurofibroma of the tongue: a case report of a child.
Güneri EA; Akoğlu E; Sütay S; Ceryan K; Sağol O; Pabuçcuoğlu U
Turk J Pediatr; 2006; 48(2):155-8. PubMed ID: 16848118
[TBL] [Abstract][Full Text] [Related]
23. Laryngeal involvement in neurofibromatosis.
Willcox TO; Rosenberg SI; Handler SD
Ear Nose Throat J; 1993 Dec; 72(12):811-2, 815. PubMed ID: 8313866
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha for neurofibromas.
Kebudi R; Ayan I
Med Pediatr Oncol; 1996 Mar; 26(3):220-2. PubMed ID: 8544807
[No Abstract] [Full Text] [Related]
25. Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects.
Baldo F; Grasso AG; Cortellazzo Wiel L; Maestro A; Trojniak MP; Murru FM; Basso L; Magnolato A; Bruno I; Barbi E
Paediatr Drugs; 2020 Aug; 22(4):417-423. PubMed ID: 32533336
[TBL] [Abstract][Full Text] [Related]
26. Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real-world case series.
Coltin H; Perreault S; Larouche V; Black K; Wilson B; Vanan MI; Gupta AA; Morgenstern DA; Parkin PC; Bouffet E; Ramaswamy V
Pediatr Blood Cancer; 2022 Aug; 69(8):e29633. PubMed ID: 35289492
[TBL] [Abstract][Full Text] [Related]
27. Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.
Prada CE; Rangwala FA; Martin LJ; Lovell AM; Saal HM; Schorry EK; Hopkin RJ
J Pediatr; 2012 Mar; 160(3):461-7. PubMed ID: 21996156
[TBL] [Abstract][Full Text] [Related]
28. Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Fisher MJ; Shih CS; Rhodes SD; Armstrong AE; Wolters PL; Dombi E; Zhang C; Angus SP; Johnson GL; Packer RJ; Allen JC; Ullrich NJ; Goldman S; Gutmann DH; Plotkin SR; Rosser T; Robertson KA; Widemann BC; Smith AE; Bessler WK; He Y; Park SJ; Mund JA; Jiang L; Bijangi-Vishehsaraei K; Robinson CT; Cutter GR; Korf BR; ; Blakeley JO; Clapp DW
Nat Med; 2021 Jan; 27(1):165-173. PubMed ID: 33442015
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
[TBL] [Abstract][Full Text] [Related]
30. Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas.
Karmazyn B; Cohen MD; Jennings SG; Robertson KA
Pediatr Radiol; 2012 Oct; 42(10):1218-22. PubMed ID: 22722872
[TBL] [Abstract][Full Text] [Related]
31. Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance.
Valeyrie-Allanore L; Ortonne N; Lantieri L; Ferkal S; Wechsler J; Bagot M; Wolkenstein P
Br J Dermatol; 2008 May; 158(5):1008-12. PubMed ID: 18363759
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study.
Weiss B; Widemann BC; Wolters P; Dombi E; Vinks A; Cantor A; Perentesis J; Schorry E; Ullrich N; Gutmann DH; Tonsgard J; Viskochil D; Korf B; Packer RJ; Fisher MJ
Neuro Oncol; 2015 Apr; 17(4):596-603. PubMed ID: 25314964
[TBL] [Abstract][Full Text] [Related]
33. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.
Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of spinal cord compression from plexiform neurofibromas in patients with neurofibromatosis 1.
Pollack IF; Colak A; Fitz C; Wiener E; Moreland M; Mulvihill JJ
Neurosurgery; 1998 Aug; 43(2):248-55; discussion 255-6. PubMed ID: 9696077
[TBL] [Abstract][Full Text] [Related]
35. Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging.
Solomon J; Warren K; Dombi E; Patronas N; Widemann B
Comput Med Imaging Graph; 2004 Jul; 28(5):257-65. PubMed ID: 15249071
[TBL] [Abstract][Full Text] [Related]
36. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.
Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G
Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study.
Weiss B; Widemann BC; Wolters P; Dombi E; Vinks AA; Cantor A; Korf B; Perentesis J; Gutmann DH; Schorry E; Packer R; Fisher MJ
Pediatr Blood Cancer; 2014 Jun; 61(6):982-6. PubMed ID: 24851266
[TBL] [Abstract][Full Text] [Related]
38. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.
Dombi E; Solomon J; Gillespie AJ; Fox E; Balis FM; Patronas N; Korf BR; Babovic-Vuksanovic D; Packer RJ; Belasco J; Goldman S; Jakacki R; Kieran M; Steinberg SM; Widemann BC
Neurology; 2007 Feb; 68(9):643-7. PubMed ID: 17215493
[TBL] [Abstract][Full Text] [Related]
39. Solitary oral plexiform neurofibroma: review of literature and report of a case.
Zwane NP; Noffke CE; Raubenheimer EJ
Oral Oncol; 2011 Jun; 47(6):449-51. PubMed ID: 21571578
[TBL] [Abstract][Full Text] [Related]
40. Experimental therapy for neurofibromatosis I shows promise: cancer drug shrinks some plexiform neuromas.
Am J Med Genet A; 2013 Feb; 161A(2):viii-ix. PubMed ID: 23348988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
